MétaCan
Menu
Back to cohort
Record W4220794223 · doi:10.1002/jcsm.12960

Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from <i>the International Lipid Expert Panel</i> (ILEP)

2022· review· en· W4220794223 on OpenAlexfundno aff
Peter E. Penson, Éric Bruckert, David Marais, Željko Reiner, Matteo Pirro, Amirhossein Sahebkar, Gani Bajraktari, Erkin М Мirrakhimov, Manfredi Rizzo, Dimitri P. Mikhailidis, Alexandros Sachinidis, Dan Gaiță, Gustavs Latkovskis, Mohsen Mazidi, Peter P. Tóth, Daniel Pella, Fahad Alnouri, Arman Postadzhiyan, Hung‐I Yeh, G.B. John Mancini, Stephan von Haehling, Maciej Banach

Bibliographic record

VenueJournal of Cachexia Sarcopenia and Muscle · 2022
Typereview
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsnot available
FundersNIH Clinical CenterRespicardiaChugai PharmaceuticalEsperion TherapeuticsSorbonne UniversitéCliniques Universitaires Saint-LucUniversity Of Al-QadisiyahServierAlexandria UniversityMedizinische Universität WienValeant Pharmaceuticals InternationalUniversität WienInstitut National de la Santé et de la Recherche MédicaleHebrew University of JerusalemAmryt PharmaInstitute of GeneticsAstraZenecaAmarin CorporationMylanUniverzita Karlova v PrazeIonis Pharmaceuticalslékařská fakulta Univerzity KarlovyUniversità di BolognaTeva Pharmaceutical IndustriesHelsinnUmeå UniversitetDanoneKowa CompanyUniwersytet ŁódzkiWestern Sydney Local Health DistrictSanofiDeutsches Zentrum für Herz-KreislaufforschungNovo NordiskAmgenPfizerEli Lilly and CompanyAbbott Laboratories
KeywordsMedicineStatinNocebo EffectHydroxymethylglutaryl-CoA Reductase InhibitorsPosition paperPosition (finance)Physical therapyIntensive care medicineAlternative medicineInternal medicinePathologyPlacebo

Abstract

fetched live from OpenAlex

Statin intolerance is a clinical syndrome whereby adverse effects (AEs) associated with statin therapy [most commonly statin-associated muscle symptoms (SAMS)] result in the discontinuation of therapy and consequently increase the risk of adverse cardiovascular outcomes. However, complete statin intolerance occurs in only a small minority of treated patients (estimated prevalence of only 3-5%). Many perceived AEs are misattributed (e.g. physical musculoskeletal injury and inflammatory myopathies), and subjective symptoms occur as a result of the fact that patients expect them to do so when taking medicines (the nocebo/drucebo effect)-what might be truth even for over 50% of all patients with muscle weakness/pain. Clear guidance is necessary to enable the optimal management of plasma in real-world clinical practice in patients who experience subjective AEs. In this Position Paper of the International Lipid Expert Panel (ILEP), we present a step-by-step patient-centred approach to the identification and management of SAMS with a particular focus on strategies to prevent and manage the nocebo/drucebo effect and to improve long-term compliance with lipid-lowering therapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.004
Threshold uncertainty score0.013

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0040.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.276
Teacher spread0.257 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations81
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Cachexia Sarcopenia and MuscleSame topicLipoproteins and Cardiovascular HealthFrench-language works237,207